HemChip®: multi-target diagnostics
Many markers in one run, results in under 30 minutes, wherever they are needed.
Comparison
HemChip® vs traditional testing
| Criteria | Traditional testing | HemChip® |
|---|---|---|
| Time to result | Hours to days | < 30 minutes |
| Equipment cost | Very high ($50K–$500K) | Low (compact reader) |
| Targets | 1–2 per run | Many at once |
| Staffing | Trained technicians | Non-specialists |
| Location | Central laboratory | On site, in the field |
| Output data | Manual, hard to integrate | Digital, AI-ready |
Market
Point-of-care & biochip market
Demand for fast, decentralised analysis keeps growing.
POC market 2024
$47.8B
POC market 2030 · 5.8% CAGR
$68.5B
Biochip market 2030 · 10–12% CAGR
$40B+
Multi-target diagnostics market
$20–25B
Where it is used
Analysis anywhere
- Clinics and community health facilities
- Continuous health monitoring
- In the field: epidemiology, veterinary, agriculture
- Emergencies and emerging outbreaks
HemChip® is a product of Hememics Biotechnologies, Inc. (USA). Medical and diagnostic use in Vietnam will follow the applicable regulations.




Partnering to build the technology of the future
Companies, research institutions and technology partners interested in graphene, biochips or our factory project – get in touch.
